Zed is a speed demon you can't ignore.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

Artificial intelligence, or AI, in the financial sector has moved from the testing lab to the investment desk. Nvidia Corp.'s (ticker: NVDA) 2026 State of AI in Financial Services Report found that ...

With nearly two decades of retail management and project management experience, Brett Day can simplify complex traditional and Agile project management philosophies and methodologies and can explain ...

Replimune Group faces a pivotal FDA decision for RP1 in advanced melanoma, with a Sell rating reflecting approval odds and the current price. RP1 demonstrates real antitumor activity and durable ...

In 2026, most companies are using AI in some fashion, as companies feel pressure to keep up with competitive industry dynamics and experiment with the new technology. The stocks on this list were ...